Safety and Utilization of Influenza Immunization in Children With Inflammatory Bowel Disease

OBJECTIVE: Influenza immunization is recommended for children with IBD, however safety concerns may limit uptake. This study assessed whether immunization was associated with adverse events in IBD patients using a population-based database of children with IBD. METHODS: All children <19 years diagnosed with IBD in Ontario, Canada between 1999–2009 were identified using health administrative data, and matched to non-IBD controls. Self-controlled case series (SCCS) analyses determined health services event rates (outpatient visits, hospitalizations and emergency visits) in any 2-week risk period to 180 days post-immunization compared to a no-risk control period. Relative incidence (RI) was calculated for overall and IBD-related events and rates were compared between IBD cases and controls using relative incidence ratios (RIR). RESULTS: A total of 4916 IBD patients were matched to 21 686 controls. IBD patients were more likely to have received immunization than controls (25.3% vs 13.2%, P < .001). No increased event rates existed in IBD cases during risk periods (pooled RI 0.95, 95% CI 0.84–1.07), including hospitalizations and emergency visits. There was a slightly higher event rate in IBD cases versus controls for days 3–14 (RIR 1.60, 95% CI 1.05–2.44, P = .03). IBD-related visit rates were lower in risk periods compared to control period (pooled RI 0.81, 95% CI 0.68–0.96). CONCLUSIONS: There was no increase in health services use in the post-vaccine risk period in IBD patients, and there was evidence for a protective effect of influenza immunization against IBD-related health services use. Influenza immunization is safe in children with IBD and should be encouraged to improve poor coverage rates.

[1]  H. Tilg,et al.  Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.

[2]  K. Wilson,et al.  Vaccine and Immunization Surveillance in Ontario (VISION) - using linked health administrative databases to monitor vaccine safety. , 2012, Vaccine.

[3]  H. Whittle,et al.  Vaccine programmes must consider their effect on general resistance , 2012, BMJ : British Medical Journal.

[4]  R. Fedorak,et al.  Inadequate knowledge of immunization guidelines: A missed opportunity for preventing infection in immunocompromised IBD patients , 2012, Inflammatory bowel diseases.

[5]  G. Kaplan,et al.  Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease , 2012, Inflammatory bowel diseases.

[6]  S. Wasan,et al.  Vaccinating the inflammatory bowel disease patient: Deficiencies in gastroenterologists knowledge , 2011, Inflammatory bowel diseases.

[7]  T. To,et al.  Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994–2007)1,2 , 2011, Inflammatory bowel diseases.

[8]  T. To,et al.  Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universal-access healthcare system. , 2011, The Journal of pediatrics.

[9]  K. Wilson,et al.  Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations - a population based study of 969,519 vaccination events. , 2011, Vaccine.

[10]  J. Mössner,et al.  Vaccination coverage in immunosuppressed patients: results of a regional health services research study. , 2011, Deutsches Arzteblatt international.

[11]  E. Louis,et al.  H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy , 2011, Gut.

[12]  A. Griffiths,et al.  Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends , 2011, Inflammatory bowel diseases.

[13]  J. Marshall,et al.  Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus? , 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[14]  T. To,et al.  Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data , 2009, Gut.

[15]  B. Sands.  Response to Letter by Field et al, Influenza Vaccinations: Should They Really be Encouraged for IBD Patients Being Treated with Immunosuppressives? , 2009 .

[16]  B. Korelitz,et al.  Influenza vaccinations: should they really be encouraged for IBD patients being treated with immunosuppressives? , 2009, Inflammatory bowel diseases.

[17]  A. Guttmann,et al.  Influenza vaccination rates in Ontario children: implications for universal childhood vaccination policy. , 2009, Vaccine.

[18]  A. Bousvaros,et al.  Immune Response to Influenza Vaccine in Children With Inflammatory Bowel Disease , 2009, The American Journal of Gastroenterology.

[19]  CIHI Data Quality Study of the 2008–2009 Discharge Abstract Database , 2009 .

[20]  Louis J. Cohen,et al.  Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  A. Griffiths,et al.  Intercenter variation in initial management of children with Crohn's disease , 2007, Inflammatory bowel diseases.

[22]  Young Sook Park,et al.  [A case of ulcerative colitis relapsed by influenza vaccination]. , 2007, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[23]  D. Manuel,et al.  Using OHIP physician billing claims to ascertain individual influenza vaccination status. , 2007, Vaccine.

[24]  S. Targan,et al.  Patients with Inflammatory Bowel Disease are at Risk for Vaccine-Preventable Illnesses , 2005, The American Journal of Gastroenterology.

[25]  B. Sands,et al.  Guidelines for immunizations in patients with inflammatory bowel disease. , 2004, Inflammatory bowel diseases.

[26]  D. Moneret-vautrin,et al.  Pancolitis after influenza vaccination , 2004, Allergy.

[27]  J. Richards,et al.  Proceedings of Statistics Canada Symposium 2001 Achieving Data Quality in a Statistical Agency: a Methodological Perspective the Data Quality Study of the Canadian Discharge Abstract Database , 2022 .

[28]  R. Knobler,et al.  A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis , 1997, Neurology.

[29]  C P Farrington,et al.  Case series analysis of adverse reactions to vaccines: a comparative evaluation. , 1996, American journal of epidemiology.

[30]  Farrington Cp.  Relative incidence estimation from case series for vaccine safety evaluation. , 1995 .

[31]  C P Farrington,et al.  Relative incidence estimation from case series for vaccine safety evaluation. , 1995, Biometrics.

[32]  A. Teufel,et al.  Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. , 1994, The Journal of rheumatology.

[33]  Amy,et al.  VACCINATIONS AND THE RISK OF RELAPSE IN MULTIPLE SCLEROSIS , 2022 .